Zynex Inc (ZYXI)

NASDAQ
Currency in USD
2.24
-0.06(-2.61%)
Closed·
After Hours
2.240.00(0.00%)
·
ZYXI Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 12 days
Fair Value
Day's Range
2.182.33
52 wk Range
1.6610.62
Key Statistics
Edit
Prev. Close
2.3
Open
2.31
Day's Range
2.18-2.33
52 wk Range
1.66-10.62
Volume
106.16K
Average Volume (3m)
227.37K
1-Year Change
-74.39%
Book Value / Share
0.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ZYXI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.00
Upside
+167.86%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Zynex Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Zynex Company Profile

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; and M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body; and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, braces for rehabilitation support for knee and wrist, and Dynacomp for cold compression therapy. Further, it develops Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser photoplethysmographic patient monitoring device; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; and fluid monitoring and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Zynex Inc SWOT Analysis


Market Dynamics
Explore Zynex's position in the $900 million pain management market and its expansion into the $3.7 billion patient monitoring secto
Financial Crossroads
Delve into Zynex's recent financial performance, including revenue growth and earnings challenges, and its impact on future projections
Strategic Shifts
Uncover Zynex's product diversification strategy and sales force optimization efforts aimed at long-term growth and improved efficiency
Analyst Outlook
Discover varied analyst perspectives, with price targets ranging from $12 to $16, reflecting both optimism and caution about Zynex's future prospects
Read full SWOT analysis

Zynex Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of -$0.33 missed $0.06 forecast; revenue of $26.58M fell short of $53.47M expectation; stock dropped 6.73% after hours
  • Revenue decreased from $46.5M in Q1 2024 to $26.6M in Q1 2025; company maintains 79.7% gross profit margin
  • Zynex forecasts Q2 2025 revenue of $27M with EPS loss of $0.20; aims for $800M annual revenue long-term
  • New NICO Pulse Oximeter launch expected to generate revenue in 2026; company restructuring to operate without TRICARE business
  • Analyst price targets range $5-$15; InvestingPro data shows 72% YTD stock decline, market cap at $68.92M
Last Updated: 30-04-2025, 02:22 am
Read Full Transcript

Compare ZYXI to Peers and Sector

Metrics to compare
ZYXI
Peers
Sector
Relationship
P/E Ratio
−9.1x−3.8x−0.5x
PEG Ratio
0.05−0.110.00
Price/Book
3.3x2.6x2.6x
Price / LTM Sales
0.4x3.0x3.1x
Upside (Analyst Target)
160.9%49.3%45.7%
Fair Value Upside
Unlock7.9%5.7%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 6.00
(+167.86% Upside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.33 / 0.06
Revenue / Forecast
26.58M / 53.47M
EPS Revisions
Last 90 days

ZYXI Income Statement

FAQ

What Is the Zynex (ZYXI) Stock Price Today?

The Zynex stock price today is 2.24.

What Stock Exchange Does Zynex Trade On?

Zynex is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Zynex?

The stock symbol for Zynex is "ZYXI."

What Is the Zynex Market Cap?

As of today, Zynex market cap is 68.04M.

What Is Zynex's Earnings Per Share (TTM)?

The Zynex EPS (TTM) is -0.23.

When Is the Next Zynex Earnings Date?

Zynex will release its next earnings report on 23 Jul 2025.

From a Technical Analysis Perspective, Is ZYXI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Zynex Stock Split?

Zynex has split 1 times.

How Many Employees Does Zynex Have?

Zynex has 1000 employees.

What is the current trading status of Zynex (ZYXI)?

As of 11 Jul 2025, Zynex (ZYXI) is trading at a price of 2.24, with a previous close of 2.30. The stock has fluctuated within a day range of 2.18 to 2.33, while its 52-week range spans from 1.66 to 10.62.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.